Digoxin study for infants with single ventricle heart disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests how the body processes the drug digoxin in infants born with a single lower heart chamber (single ventricle). It aims to improve understanding of the right dose for these babies before their second heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Infants diagnosed with single ventricle congenital heart disease
- Baby has had the first heart surgery (stage 1 palliation) but not the second (stage 2 palliation)
- Baby was 30 days old or younger at the time of the first surgery
- Baby is younger than 6 months old when starting the study
- The doctor has already decided to give digoxin through a feeding tube or by mouth
- Parent or legal guardian agrees to the study and signs a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
This study is for very premature babies (born before 33 weeks) who have low blood flow from the heart. It tests different doses of dobutamine, a medicine that helps the heart pump stronger, to find the safest and most effective dose.
This study records newborn heart measurements (using medical imaging) to compare babies with certain congenital heart defects to healthy-term babies. The goal is to see how well one test matches another, which may help doctors better understand heart conditions in newborns.
This trial tests whether an infusion of heart stem/progenitor cells can improve outcomes for children with a single working heart chamber (single ventricle) who are scheduled for the next surgical stage (Glenn or Fontan). It may help the heart function after surgery, but participation depends on several heart, lung, brain, and overall health safety criteria.
This trial tests whether a beta-blocker called propranolol can improve how well heart muscle cells work in very young babies with certain congenital heart conditions. It mainly looks at safety and how the medicine affects the heart, which could help guide future treatments.
This trial tests whether digoxin, a heart medication, can help people who were recently hospitalized for heart failure with a weak heart pump. It aims to see if it improves symptoms and daily activity.
Hear when a new Single-ventricle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.